Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001127602-24-014445

EVP Research & Development sold 15,547 shares at $65.11 ($1,012,265)

  • EVP Research & Development acquired 14,186 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Malik Fady Ibraham · EVP Research & Development

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-07 Exercise or conversion : show line 1 in the form 10b5-1 +14,186 $6.67 $94,621 152,603 D
2024-05-07 Sale : show line 2 in the form 10b5-1 −14,186 $65.11 $923,650 138,417 D
2024-05-07 Sale : show line 3 in the form 10b5-1 −1,361 $65.11 $88,615 137,056 D
Open-market sales · 15,547 sh · avg $65.11 · $1,012,265

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-07 Exercise or conversion : show line 4 in the form 10b5-1 Incentive Stock Option (Right to Buy) −14,186 0 D
Loading xslF345X05/form4.xml…